The Food and Drug Administration has been in "sustained and ongoing" discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients "as quickly as possible, as appropriate," the agency said.
From delaying Arctic expeditions to canceling vital global climate conferences, the coronavirus pandemic has hindered global progress on fighting climate change and threatens effective natural disaster forecasting as hurricane season approaches.
Oil prices jumped on Wednesday after data from the American Petroleum Institute showed a smaller-than-expected build in US inventories, and on hope that economies will soon reopen.
Chris Whitty, England's chief medical officer, told reporters Monday it is "entirely plausible" that Covid-19 causes the inflammatory illness in children.
Gilead Sciences said preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved.
Some 1.6 billion people in informal work are in danger of losing income due to the coronavirus pandemic, the International Labour Organisation has estimated.
Stocks jumped on positive data from a potential coronavirus treatment from Gilead Sciences while investors digested a sharp drop in U.S. economic activity.
Researchers at Cambridge University and the U.S. Federal Reserve Board found that imposing no lockdown measures in the face of Covid-19 was "extremely risky" for developed economies.
This marked the first negative GDP reading since the 1.1% decline in the first quarter of 2014 and the worst level since the 8.4% plunge in Q4 of 2008 during the worst of the financial crisis
Major U.S. energy companies are taking an axe to their rig numbers, deepening production cuts for the industry that in the last few years made America the world's number one oil producer.
Moody's has downgraded its outlook for banking systems in South Africa, Nigeria and Morocco amid concerns over the fallout from the coronavirus pandemic and tumbling oil prices.